Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Global, local actions can tackle ‘unprecedented pace’ of climate change, heart disease Regina Schaffer
-
- Advances in HF, hypertrophic cardiomyopathy management among top news of 2022 Regina Schaffer; Katie Kalvaitis
- BP control, management worsened during COVID-19 pandemic Regina Schaffer
- Bromocriptine appears to drop BP, improve arterial stiffness in teens with type 1 diabetes Scott Buzby
- CVD remains leading cause of death globally Regina Schaffer
- Exercising in the morning could reduce CVD risk Kate Young
- Fatty liver disease conditions ‘change the healthy heart to a failing heart’ Regina Schaffer
- FDA panel declines to support approval of omecamtiv mecarbil Regina Schaffer
- Food insecurity has increased over time in patients with CVD Erik Swain
-
- High Lp(a) in childhood linked to adult ASCVD risk Scott Buzby
- Insulin resistance, hyperinsulinemia primary drivers of atherosclerotic CVD Regina Schaffer
- Loop diuretic choice does not reduce all-cause death in HF: TRANSFORM-HF Regina Schaffer
- Lp(a) ‘should be measured at least once’ in adults to target CV risk Regina Schaffer
- Offspring of mothers with preeclampsia have elevated risk for stroke, heart disease Erik Swain
- Pipeline Pulse: A look at tirzepatide, ziltivekimab and obicetrapib Seth J. Baum, MD
- Presence of severe marital stress tied to poor 1-year outcomes after acute MI Scott Buzby
- Radiofrequency renal denervation lowers BP despite missing primary efficacy endpoint Erik Swain
-
- Residual CVD risk varies; individualized treatments best to combat it Erik Swain
- Risk prediction from low HDL varies by race Scott Buzby
- Self-expanding TAVR tied to less structural valve deterioration at 5 years vs. surgery Scott Buzby
- Trial does not support routine antithrombotic use in ill outpatients with COVID-19 Scott Buzby
- Walking 10K steps per day may slow aortic dilation in pediatric Marfan syndrome Scott Buzby
- ‘ZIP code matters’: COVID-19 hospitalizations, CV outcomes differ by where people live Regina Schaffer
- Drug and Device Update
- EMPA-HEART 2
-
- FRESH
- NOVA
- PRECISE
- RAPID
- RESPECT-EPA
- STRONG-HF
- TEXT MY MEDS NOLA